PRP Hair Restoration

Human blood contains stem cells and autologous blood products that contain essential growth factors that assist in the regeneration of tissue and healing. Evidence supports PRP therapy as a promising treatment option to promote hair growth. Blood is drawn in office, similar to a routine blood test. The blood is then spun in a centrifuge and the PRP is separated. It is then removed from the rest of the blood. An anesthesia block may be administered to the scalp, allowing for reduced discomfort. The concentrated PRP is injected into the scalp. There is no sedation involved with this procedure, so the patient is then free to drive home without assistance.

There are some factors which make PRP hair restoration inadvisable. Patients with a history of heavy smoking, drug use and alcohol use are not recommended to receive PRP hair restoration.

Exosomes are are naturally present in stem cells and are at the forefront of a regenerative medicine breakthrough. They’re essentially the messengers of the stem cell world. Exosomes travel around your body carrying signals from cell to cell and providing status updates.

Scientists have discovered that when a healthy cell sends an exosome to an unhealthy cell, the unhealthy cell can begin to improve and regenerate. Using this basic theory, scientists have found that exosomes are the better alternative to a stem cell therapy to help speed up the regenerative properties that stem cells already possess, including hair regeneration. Many top physicians across the United States are currently using Exosomes for the treatment of hair restoration.

The safety and tolerability of Exosomes is well-know. However, no scientific studies or case reports are available in hair restoration patients to determine efficacy of Exosomes. This is a very new product that has great hope. No guarantee of success can be made with this FDA-approved product, and clinical responses to these medical therapies vary from one patient to another. Treatment for hair loss with novel regenerative therapies is exciting with safety and tolerability well-established, but efficacy studies still outstanding.